Integrative genomics identifies the molecular basis of resistance to Azacitidine therapy in Myelodysplastic Syndromes Meeting Abstract

   

Authors:	Unnikrishnan, A.; Papaemmanuil, E.; Beck, D.; Verma, A.; Kumari, A.; Woll, P.; Richards, L.; Knezevic, K.; Chandrakanthan, V.; Thoms, J.; Tursky, M.; Huang, Y.; Ali, Z.; Olivier, J.; Galbraith, S.; Kulasekararaj, A.; Tobiasson, M.; Karimi, M.; Pellagatti, A.; Wilson, S.; Lindeman, R.; Young, B.; Ramakrishna, R.; Arthur, C.; Stark, R.; Crispin, P.; Curnow, J.; Warburton, P.; Roncolato, F.; Boultwood, J.; Lynch, K.; Jacobsen, S.; Mufti, G.; Hellstrom-Lindberg, E.; MacKenzie, K.; Wong, J.; Campbell, P.; Pimanda, J.
Abstract Title:	Integrative genomics identifies the molecular basis of resistance to Azacitidine therapy in Myelodysplastic Syndromes
Meeting Title:	21st Congress of the European Hematology Association (EHA)
Journal Title:	Haematologica
Volume:	101
Issue:	Suppl. 1
Meeting Dates:	2016 Jun 9-12
Meeting Location:	Copenhagen, Denmark
ISSN:	0390-6078
Publisher:	Ferrata Storti Foundation
Date Published:	2016-06-01
Start Page:	157
End Page:	158
Language:	English
ACCESSION:	WOS:000379484600349
PROVIDER:	wos
PMCID:	PMC4894295
Notes:	Meeting Abstract: S443 -- Source: Wos